A Trial Comparing Chemotherapy Versus Novel Immune Checkpoint Inhibitor (Pembrolizumab) Plus Chemotherapy in Treating Relapsed/Refractory Classical Hodgkin Lymphoma
Clinical trial NCT05711628 · WITHDRAWN
Trial details
- NCT number
- NCT05711628
- Sponsor
- National Cancer Institute (NCI)
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-10
- Primary completion
- 2028-06-30
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.